Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Earnings Routine +

EverGen Infrastructure Reports Q1 2026 Results

EverGen Infrastructure Confirms Financing and Offtake Execution Amidst Continued Operational Turnaround

Executive Summary
  • Financial Performance: Q1 2026 revenue increased 38% YoY to $2.6 million; Net loss reduced by 42% to $(697) thousand; EBITDA turned positive at $712 thousand (up from $(33) thousand).
  • Financing: Closed a $13.0 million asset-level credit facility with Farm Credit Canada (FCC) and an operating line of credit. Proceeds used to pay down $12.0 million of corporate debt, reducing total corporate indebtedness to ~$1.1 million.
  • Equity Financing: Closed second tranche of non-brokered private placement for approximately $1.9 million gross proceeds (3,152,441 shares at $0.60/share).
  • Operational Milestones: Regulatory approval received to construct an anaerobic digester at Pacific Coast Renewables (PCR) RNG Expansion project. 20-Year Offtake Agreement with FortisBC Energy Inc. for Fraser Valley Biogas is now in effect.
  • Production: RNG production increased 23% YoY to 52,756 gigajoules; Organic compost and soil sales up 108%.
Material Impact
  • Execution of Known Strategy: The financing ($13M FCC facility) and Offtake Agreement (FortisBC) were previously announced in January 2026. Closing these deals confirms management's execution capability but does not introduce new strategic surprises to the market.
  • Balance Sheet Improvement: Reducing corporate debt from ~$13M+ down to $1.1M is a significant de-risking event, aligning debt with asset cash flows as stated by CEO Chase Edgelow. This materially improves financial flexibility but was anticipated following the January announcements.
  • Profitability Trend: The return to positive EBITDA ($712k) follows Q3 2025 and Q4 2025 results which also showed profitability or reduced losses. This indicates a consistent operational turnaround rather than a one-off event.
  • Market Expectation: Given the public announcements in Jan/Feb/March regarding these specific financings and agreements, the market likely priced in this execution. The news validates the plan but lacks the "unexpected" element required for a Material - Positive rating.
  • Data Integrity Risk: A critical discrepancy exists between the News data (EverGen Infrastructure/RNG) and the provided Transcript Context (Evogene/AI Pharma). While the News describes EverGen, the Transcript details Evogene's AI/Pharma business. This mismatch creates significant confusion risk for investors relying on transcript sentiment analysis for this specific company.
EVGN · Price
Company Overview
  • Business Model: Renewable Natural Gas (RNG) production, waste processing, and organic fertilizer sales.
  • Flagship Projects:
    • Fraser Valley Biogas (FVB): Produces RNG with a secured 20-year offtake agreement with FortisBC Energy Inc.
    • Pacific Coast Renewables (PCR): Expansion project approved for anaerobic digester construction to increase capacity.
    • GrowTEC: Contributing facility to the RNG portfolio output.
  • Development Stage: Operational production facilities with active expansion and financing restructuring phases.
Read the original news release →

More from EverGen Infrastructure Corp.